The place of diuretics in preventing cardiovascular events

N M Kaplan1

  • 1The University of Texas Southwestern Medical Center, Dallas, TX 75235-8899, USA. norman.kaplan@utsouthwestern.edu

Insights

Low-dose diuretics are a recommended first-line treatment for hypertension, offering significant cardiovascular protection, especially in older adults. They are well-tolerated, with minimal side effects, and enhance the effectiveness of other antihypertensive medications.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Diuretics are recommended for initial antihypertensive therapy by major guidelines.
  • Renal dysfunction and impaired sodium excretion are implicated in hypertension pathogenesis.
  • Subtle renal insufficiency is a common consequence of uncontrolled hypertension.

Purpose of the Study:

  • To review the rationales and evidence supporting the use of low-dose diuretics in hypertension management.
  • To highlight the benefits of diuretics as monotherapy and in combination with other antihypertensive agents.

Main Methods:

  • Review of existing clinical guidelines and randomized controlled trials.
  • Analysis of comparative trials evaluating diuretic-based therapy versus newer agents.
  • Assessment of diuretic effects on cardiovascular morbidity and mortality.

Main Results:

  • Diuretic-based therapy significantly reduces cardiovascular morbidity and mortality, particularly in elderly patients.
  • Diuretics provide comparable cardiovascular protection to newer antihypertensive agents.
  • Low-dose diuretics enhance the efficacy of all other classes of antihypertensive drugs.

Conclusions:

  • Low-dose diuretics are a rational and effective choice for initial antihypertensive therapy.
  • Their ability to enhance other agents makes them crucial for achieving lower blood pressure goals.
  • Minimal side effects at low doses contribute to their favorable safety profile.

Related Concept Videos

Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...